NEW: China’s Inspur could be on the hook for more than $200 million if HPE convinces a federal jury the cloud-computing company, included on a US government threat list, used patented server technology without permission, according to a court filing. news.bloomberglaw.com/ip-law/hp-ente…

💉: GSK revived decade-old patent applications acquired from Novartis to claim Comirnaty Covid-19 vaccines infringe them, @Pfizer & BioNTech SE told a federal judge, denying the allegations & insisting their products comply w/ U.S. FDA regulations. news.bloomberglaw.com/ip-law/gsk-pat…

NEW: @Intel escaped a 2019 lawsuit as a federal judge cited a patent holder’s “contradictory positions” on the scope of its invention in ruling the chipmaker’s microprocessors don’t infringe. PACT XPP Schweiz AG “is bound by the words it used,” judge said. news.bloomberglaw.com/ip-law/intel-b…

NEW: German chip maker Infineon filed a patent-infringement complaint asking the US International Trade Commission to ban imports of Innoscience’s gallium-nitride-based semiconductor devices, the 2nd such trade action targeting the Chinese company. news.bloomberglaw.com/ip-law/infineo…

NEW: Lupin’s generic version of Jynarque doesn’t infringe two OtsukaUS patents for the blockbuster kidney disease treatment, a federal judge in Delaware ruled, also canceling one of them that would’ve expired in August 2028. news.bloomberglaw.com/ip-law/lupin-c…

⚡️🚌: WiTricity sued @IdeanomicsHQ alleging its WAVE-branded wireless charging systems—designed for mass transit & logistics applications—infringe five patents for wireless energy transfer tech. The suit targets public transit systems in FL, TX, CA & WA. news.bloomberglaw.com/ip-law/witrici…

NEW: @Biogen and Alkermes’ lawsuit over Zydus Lifesciences Ltd.’s proposed generic version of Vumerity is down to the validity of three asserted patents after Zydus agreed its copy of the multiple sclerosis drug infringes. A bench trial is set for late July 2025. news.bloomberglaw.com/ip-law/biogens…

NEW: Astellas Pharma US, @Pfizer & UC Newsroom allege Qilu Pharmaceutical's Xtandi copies infringe 2 patents for blockbuster prostate cancer drug. One exp. 9/2033, latest of Xtandi's 4 Orange Book-listed patents. Xtandi US sales (FY2023)=$2.6B, 23.7% $ALPMY revenue. news.bloomberglaw.com/ip-law/astella…

NEW: BioNTech SE owes Penn royalties on a greater share of its Covid-19 vaccine’s $75 billion in global sales, according to a lawsuit alleging underpayment for patents developed by Nobel Prize winners whose mRNA technology was crucial for Comirnaty. news.bloomberglaw.com/ip-law/penn-su…

BREAKING: @Pfizer’s $107.5 million verdict will stand, as a federal judge rejected AstraZeneca’s request for a new trial after a Delaware jury found $AZN's blockbuster cancer drug Tagrisso infringes two patents for $PFE's competing Vizimpro. news.bloomberglaw.com/ip-law/pfizers…

NEW: Pacira BioSciences, Inc. lost a ruling to Jiangsu Hengrui Pharms. Co. and its eVenus unit as a federal judge canceled a patent for Exparel, a long-acting injectable painkiller for managing postsurgical pain. $PCRX stock plunged by >47% to close at $11.70 a share. news.bloomberglaw.com/ip-law/pacira-…

DOWN THE RABBIT HOLE🎩: Whether @Pfizer's Comirnaty vaccines infringe an Alnylam Pharmaceuticals patent will come down to $ALNY proving the Covid-19 shots are, in fact, vaccines, a judge wrote in a ruling heavily referencing the animated 1951 film “Alice in Wonderland.” news.bloomberglaw.com/ip-law/covid-s…

A federal judge wiped out @Pfizer’s $107.5 million verdict, granting AstraZeneca’s request to invalidate two patents for $PFE's Vizimpro that a Delaware jury found $AZN's blockbuster cancer drug Tagrisso infringes. news.bloomberglaw.com/ip-law/astraze…